CNRUX | VSMPX | CNRUX / VSMPX | |
Total Expense Ratio | 0.57 | 0.02 | 2,850% |
Annual Report Gross Expense Ratio | 0.57 | 0.02 | 2,850% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 13.115 | 13.861 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 382M | 2.02T | 0% |
Annual Yield % from dividends | 0.34 | 1.15 | 29% |
Returns for 1 year | -2.43 | 16.79 | -14% |
Returns for 3 years | 33.69 | 81.30 | 41% |
Returns for 5 years | 31.49 | 86.68 | 36% |
Returns for 10 years | 119.34 | 219.76 | 54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NECCX | 14.82 | 0.02 | +0.14% |
Natixis US Equity Opportunities C | |||
VIMSX | 80.20 | N/A | N/A |
Vanguard Mid Cap Index Investor | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
BGLYX | 14.91 | N/A | N/A |
Brookfield Global Listed InfrastructureI | |||
BRWUX | 29.36 | N/A | N/A |
MFS Blended Research Growth Eq R4 |